Loading organizations...
§ Venture Capital · 767 Fifth Avenue, Suite 4200, New York, New York, 10153, United States
RSL Investments operates as a private family office and investment firm, building and managing a diversified global asset portfolio. It functions as a holding company, strategically deploying capital across various industries and geographic regions. The firm identifies and supports companies with growth potential, cultivating a robust investment ecosystem.
The inception of RSL Investments is directly linked to the financial acumen and legacy of Ronald S. Lauder. As a significant figure and son of Estée Lauder, Lauder established this firm to systematically oversee and expand his substantial family investments, professionalizing capital management. His extensive experience across corporate and entrepreneurial ventures provided the foundational insight for this dedicated investment vehicle.
Primarily serving the financial interests of the Lauder family, RSL Investments' capital supports numerous global companies. The firm’s long-term vision centers on astute, disciplined investment strategies, ensuring wealth preservation and sustainable growth for future generations through strategic placements.
RSL Investments has 1 tracked investment across 1 company. The latest tracked deal is $76.0M Series B in Quince Therapeutics in May 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2018 | Quince Therapeutics | $76.0M Series B | — | Stuart Peterson, Cowles Ventures, Founders Fund, Transformation Capital, James Hong, Breakout Ventures, Dolby Family Ventures, Epiq Capital Group, Huizenga Capital Management, Lamond Family, Pfizer, Michael Dixon, Takeda Ventures, Verily, Vulcan Capital |